Jay W. Harper
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 16
- HER2/EGFR in Cancer Research 8
- CAR-T cell therapy research 3
- Cancer Treatment and Pharmacology 3
- Peptidase Inhibition and Analysis 3
-
- Monoclonal and Polyclonal Antibodies Research 8
- Co-authors
- Marsha A. Moses (8 shared papers)Michael Klagsbrun (2 shared papers)Dmitri Wiederschain (1 shared paper)George S. Tamvakopoulos (1 shared paper)Geraldine Jackson (1 shared paper)Yuen Shing (1 shared paper)Yan Li (1 shared paper)Catherine Butterfield (1 shared paper)
- Journals
- Molecular Cancer Therapeutics (4 papers)Cancer Research (4 papers)Journal of Controlled Release (2 papers)Bioconjugate Chemistry (2 papers)Clinical Cancer Research (2 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Jay W. Harper
35 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 100
- Oncology 868
- Cancer Research 363
- Immunology and Allergy 121
- Radiology, Nuclear Medicine and Imaging 374
- Molecular Biology 796
Countries citing papers authored by Jay W. Harper
This map shows the geographic impact of Jay W. Harper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay W. Harper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay W. Harper more than expected).
Fields of papers citing papers by Jay W. Harper
This network shows the impact of papers produced by Jay W. Harper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay W. Harper. The network helps show where Jay W. Harper may publish in the future.
Co-authors
The 25 scholars most cited alongside Jay W. Harper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 337 | |
| 2 | 2017 | 120 | |
| 3 | 2015 | 115 | |
| 4 | 2018 | 109 | |
| 5 | 2006 | 105 | |
| 6 | 1999 | 103 | |
| 7 | 2009 | 102 | |
| 8 | 2009 | 100 | |
| 9 | 2012 | 87 | |
| 10 | 2006 | 78 | |
| 11 | 2001 | 70 | |
| 12 | 2011 | 57 | |
| 13 | 2016 | 52 | |
| 14 | 2007 | 45 | |
| 15 | 2017 | 41 | |
| 16 | 2017 | 40 | |
| 17 | 2015 | 35 | |
| 18 | 2019 | 34 | |
| 19 | 2013 | 33 | |
| 20 | 2021 | 30 |
About Jay W. Harper
Jay W. Harper is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Cancer Research, Molecular Biology and Organic Chemistry, having authored 37 papers that have together received 1.9k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (9 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), HER2/EGFR in Cancer Research (8 papers), Synthesis and pharmacology of benzodiazepine derivatives (5 papers), CAR-T cell therapy research (3 papers), Inflammatory mediators and NSAID effects (3 papers), Cancer Treatment and Pharmacology (3 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Oncology (868 citations), Cancer Research (363 citations), Immunology and Allergy (121 citations), Radiology, Nuclear Medicine and Imaging (374 citations) and Molecular Biology (796 citations). Jay W. Harper has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Marsha A. Moses, Michael Klagsbrun, Dmitri Wiederschain, George S. Tamvakopoulos, Geraldine Jackson, Yuen Shing, Yan Li, Catherine Butterfield, Jianmin Fang and Judah Folkman. Their work appears in journals such as Molecular Cancer Therapeutics, Cancer Research, Journal of Controlled Release, Bioconjugate Chemistry and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.